HIV Vaccines
HIV Vaccines
Long-Term Analysis Confirms Elevated HIV Risk for Some Participants in Step Vaccine Study
- Details
- Category: HIV Prevention
- Published on Tuesday, 08 May 2012 00:00
- Written by Press Release
Extended follow-up provides further data confirming the observed increase in the likelihood of becoming infected with HIV among certain participants in the Step (HVTN 054) HIV vaccine trial.
Research Offers Clues to Modest Protection in Thai HIV Vaccine Trial
- Details
- Category: HIV Prevention
- Published on Tuesday, 10 April 2012 00:00
- Written by Liz Highleyman
Researchers have learned more about how an experimental vaccine provides partial protection against HIV infection, according to a report in the April 5, 2012, issue of the New England Journal of Medicine.
CROI: Conference Overview Highlights Biomedical HIV Prevention
- Details
- Category: HIV Prevention
- Published on Tuesday, 06 March 2012 00:00
- Written by Liz Highleyman
HIV prevention was the key theme at Monday's opening press overview of the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012), taking place this week in Seattle.
CROI: Broadly Neutralizing Antibodies Can Help Fight HIV [VIDEO]
- Details
- Category: HIV Vaccines
- Published on Tuesday, 06 March 2012 00:00
- Written by Gregory Fowler
Recent discoveries about broadly neutralizing antibodies are helping advance the field of HIV vaccine development, according to Dennis Burton from the Scripps Research Institute and the Ragon Institute of MGH, MIT, and Harvard, who presented the annual Bernard Fields Lecture on Monday at the 19th Conference on Retroviruses and Opportunistic Infections (CROI 2012) in Seattle.
Vacc-4x Therapeutic HIV Vaccine Linked to Lower Viral Load in Phase IIb Study
- Details
- Category: HIV Vaccines
- Published on Tuesday, 21 February 2012 00:00
- Written by Press Release
An experimental therapeutic vaccine reduced HIV viral load among patients who remained off antiretroviral therapy (ART) for up to 24 weeks, suggesting it effectively stimulates the immune system's response to the virus, according to study finding released last week by Bionor Pharma, a Norwegian biotech company.
Web Design and Development by